Clinical Trial Update: Hepatic Impairment Study For Crizotinib In Advanced Cancer Patients [Phase 1]

View source ↗

Summary

Phase 1 hepatic impairment study of crizotinib in advanced cancer patients completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• Crizotinib (crizotinib)

Snippet

Sponsor: Pfizer | Conditions: Advanced Cancer | Phase 1 | Status: COMPLETED | Results posted: 2018-10-25